Ye Thu, MD

Address155 N Fresno St
Fresno CA 93701
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Thu YM, Van Riper SK, Higgins L, Zhang T, Becker JR, Markowski TW, Nguyen HD, Griffin TJ, Bielinsky AK. Slx5/Slx8 Promotes Replication Stress Tolerance by Facilitating Mitotic Progression. Cell Rep. 2016 May 10; 15(6):1254-65. PMID: 27134171.
      View in: PubMed
    2. Thu YM, Bielinsky AK. MCM10: one tool for all-Integrity, maintenance and damage control. Semin Cell Dev Biol. 2014 Jun; 30:121-30. PMID: 24662891; PMCID: PMC4043890.
    3. Nguyen HD, Becker J, Thu YM, Costanzo M, Koch EN, Smith S, Myung K, Myers CL, Boone C, Bielinsky AK. Unligated Okazaki Fragments Induce PCNA Ubiquitination and a Requirement for Rad59-Dependent Replication Fork Progression. PLoS One. 2013; 8(6):e66379. PMID: 23824283.
      View in: PubMed
    4. Thu YM, Bielinsky AK. Enigmatic roles of Mcm10 in DNA replication. Trends Biochem Sci. 2013 Apr; 38(4):184-94. PMID: 23332289; PMCID: PMC3608807.
    5. Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-?B impairs this drug-induced senescence. EMBO Mol Med. 2013 Jan; 5(1):149-66. PMID: 23180582; PMCID: PMC3569660.
    6. Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A. NF-?B inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the ß-catenin pathway. Oncogene. 2012 May 17; 31(20):2580-92. PMID: 21963849; PMCID: PMC3253179.
    7. Thu YM, Richmond A. NF-?B inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev. 2010 Aug; 21(4):213-26. PMID: 20685151; PMCID: PMC2939163.
    8. Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R, Richmond A. Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. Mol Cancer Ther. 2009 Mar; 8(3):636-47. PMID: 19276165; PMCID: PMC3140401.
    9. Dhawan P, Su Y, Thu YM, Yu Y, Baugher P, Ellis DL, Sobolik-Delmaire T, Kelley M, Cheung TC, Ware CF, Richmond A. The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J Biol Chem. 2008 May 30; 283(22):15399-408. PMID: 18347013; PMCID: PMC2397477.
    10. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007 Oct 28; 256(2):137-65. PMID: 17629396; PMCID: PMC2065851.
    Ye's Networks
    Derived automatically from this person's publications.
    Related Authors
    People who share related concepts with this person.
    Back to TOP